Crews Bank & Trust Acquires Shares of 2,399 Danaher Co. (NYSE:DHR)

Crews Bank & Trust acquired a new stake in Danaher Co. (NYSE:DHR) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,399 shares of the conglomerate’s stock, valued at approximately $551,000.

A number of other hedge funds also recently bought and sold shares of DHR. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the 4th quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in shares of Danaher during the 3rd quarter worth approximately $39,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Danaher during the 3rd quarter worth approximately $40,000. FSA Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter worth approximately $50,000. Finally, Darwin Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter worth approximately $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $223.16 on Friday. The company’s fifty day moving average price is $235.89 and its 200 day moving average price is $253.45. Danaher Co. has a 12 month low of $221.34 and a 12 month high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market capitalization of $161.19 billion, a P/E ratio of 42.59, a P/E/G ratio of 4.43 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same quarter last year, the company posted $2.09 EPS. As a group, sell-side analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.48%. Danaher’s dividend payout ratio is currently 20.61%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on DHR shares. Barclays lowered their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday. Robert W. Baird lowered their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday. TD Cowen increased their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. UBS Group decreased their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research report on Thursday, October 31st. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.